HK Stock Market Move | INSILICO (03696) rose more than 6% in early trading. PandaClaw, as a complete biological analysis intelligent entity, has officially launched.

date
10:00 24/03/2026
avatar
GMT Eight
English Silicon Intelligence (03696) rose more than 6% in early trading, as of the time of writing, up 3.98% to HK$51.2, with a turnover of HK$23.71 million.
INSILICO (03696) rose more than 6% in early trading, as of press time, it rose by 3.98%, to 51.2 Hong Kong dollars, with a turnover of 23.71 million Hong Kong dollars. On the news front, on March 23, according to INSILICO's official WeChat account, the company recently announced the launch of PandaClaw, a revolutionary new feature in the company's autonomous target discovery platform, PandaOmics. PandaClaw combines AI intelligent agents with biological and bioinformatics workflows, allowing researchers to use an intuitive and intelligent natural language interface to achieve automated real-time analysis, thereby efficiently completing complex biological tasks such as target discovery, indication exploration, disease hypothesis, and accelerating translational medical research. According to reports, PandaClaw is another important milestone that INSILICO has taken towards "pharmaceutical superintelligence." Within the PandaOmics system, this evolution began with the launch of ChatPandaGPT in March 2023, which allows users to interact with literature and knowledge graphs in natural language; in July 2024, INSILICO completed the iteration of this feature and internally released AskPanda, which allows users to directly query the analysis results of specific targets (Target ID) on the platform; in March 2026, based on previous practical experience, PandaClaw as a complete biological analysis intelligent agent was officially launched.